Browse by category

Sciwind Biosciences has announced positive interim results from the first four cohorts of a Phase 1 clinical trial of oral ecnoglutide...

Sciwind Biosciences has initiated of dosing in a Phase 1 clinical trial evaluating XW014, a novel oral small molecule glucagon-like...